| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
665,294 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  D Ambra Constance M |
10% Owner |
– – • |
2015-03-10 |
4 |
AS |
$17.65 |
$353,000 |
D/D |
(20,000) |
2,475,818 |
|
- |
|
| Svokos George |
Chief Commercial Officer |
• – – |
2015-03-10 |
4 |
B |
$17.72 |
$177,200 |
D/D |
10,000 |
70,673 |
2.74 |
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2015-03-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(259) |
32,362 |
|
- |
|
| Marth William S |
President and CEO |
• • – |
2015-03-05 |
4 |
B |
$17.70 |
$354,000 |
D/D |
20,000 |
414,847 |
2.81 |
- |
|
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
• – – |
2015-03-02 |
4 |
A |
$17.05 |
$128,387 |
D/D |
7,530 |
32,621 |
|
- |
|
| Marth William S |
President and CEO |
• • – |
2015-03-02 |
4 |
A |
$17.05 |
$1,000,000 |
D/D |
58,651 |
393,907 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
39,495 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
37,741 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
31,316 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
33,513 |
|
- |
|
| Oconnor Kevin |
Director |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
42,849 |
|
- |
|
| Svokos George |
Chief Commercial Officer |
• – – |
2015-03-02 |
4 |
A |
$17.05 |
$150,449 |
D/D |
8,824 |
60,673 |
|
- |
|
| Ladin Felicia I |
SVP & Treasurer |
• – – |
2015-03-02 |
4 |
A |
$17.05 |
$150,449 |
D/D |
8,824 |
33,824 |
|
- |
|
| Henderson Lori M |
SVP, Secretary & Gen. Counsel |
• – – |
2015-03-02 |
4 |
A |
$17.05 |
$180,525 |
D/D |
10,588 |
46,134 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2015-03-02 |
4 |
A |
$17.05 |
$44,995 |
D/D |
2,639 |
2,647,684 |
|
- |
|
| Cable Stuart M |
10% Owner |
– – • |
2015-03-02 |
4 |
AS |
$16.39 |
$491,736 |
I/I |
(30,000) |
3,970,983 |
|
- |
|
| Nolan Michael M |
CFO |
• – – |
2015-02-25 |
4 |
S |
$16.17 |
$80,850 |
D/D |
(5,000) |
68,318 |
|
- |
|
| Nolan Michael M |
CFO |
• – – |
2015-02-25 |
4 |
OE |
$3.43 |
$17,150 |
D/D |
5,000 |
73,318 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-23 |
4 |
S |
$16.22 |
$60,825 |
D/D |
(3,750) |
25,091 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-23 |
4 |
OE |
$5.99 |
$22,463 |
D/D |
3,750 |
28,841 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-18 |
4 |
S |
$16.46 |
$109,572 |
D/D |
(6,623) |
25,091 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-18 |
4 |
S |
$16.46 |
$109,572 |
D/D |
(6,623) |
25,091 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-18 |
4 |
OE |
$2.93 |
$14,650 |
D/D |
5,000 |
26,341 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-18 |
4 |
OE |
$2.93 |
$14,650 |
D/D |
5,000 |
26,341 |
|
- |
|
| Hagen Steven R |
SVP Pharmaceutical Dev & Mfg |
• – – |
2015-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
26,714 |
|
- |
|
620 Records found
|
|
Page 8 of 25 |
|
|
